Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.75 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.74 |
| ▸ | FAAH | O00519 | 2/20 | 0.52 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.52 |
| ▸ | F7 | P08709 | 1/20 | 0.50 |
| ▸ | F3 | P13726 | 1/20 | 0.50 |
| ▸ | GMNN | O75496 | 1/20 | 0.45 |
| ▸ | USP2 | O75604 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | APEX1 | P27695 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | BLM | P54132 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17651480 | 1.00 | TSHR (0.75) | TSHRALDH1A1FAAHTRPV1F7 | |
| SCHEMBL10628419 | 1.00 | TSHR (0.75) | TSHRALDH1A1FAAHTRPV1F7 | |
| SCHEMBL6720067 | 1.00 | TSHR (0.75) | TSHRALDH1A1FAAHTRPV1F7 | |
| SCHEMBL3514428 | 1.00 | TSHR (0.75) | TSHRALDH1A1FAAHTRPV1F7 | |
| SCHEMBL6432087 | 1.00 | TSHR (0.75) | TSHRALDH1A1FAAHTRPV1F7 | |
| SCHEMBL7099079 | 1.00 | TSHR (0.75) | TSHRALDH1A1FAAHTRPV1F7 | |
| SCHEMBL6480109 | 1.00 | TSHR (0.75) | TSHRALDH1A1FAAHTRPV1F7 | |
| SCHEMBL5489696 | 1.00 | TSHR (0.75) | TSHRALDH1A1FAAHTRPV1F7 | |
| SCHEMBL6272868 | 1.00 | TSHR (0.75) | TSHRALDH1A1FAAHTRPV1F7 | |
| SCHEMBL28211546 | 1.00 | TSHR (0.75) | TSHRALDH1A1FAAHTRPV1F7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2216318-B1 | Resolvins: Biotemplates for therapeutic interventions | BRIGHAM & WOMENS HOSPITAL (US) | 2018-10-10 | — | — | EP | disclosed |
| US-9364454-B2 | Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2016-06-14 | — | — | US | disclosed |
| US-8933270-B2 | Use of docasatrienes, resolvins, and their stable analogs in the treatment of airway diseases and asthma | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2015-01-13 | — | — | US | disclosed |
| US-20140179630-A1 | USE OF DOCASATRIENES, RESOLVINS, AND THEIR STABLE ANALOGS IN THE TREATMENT OF AIRWAY DISEASES AND ASTHMA | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2014-06-26 | — | — | US | disclosed |
| US-8569542-B2 | Use of docosatrienes, resolvins, and their stable analogs in the treatment of airway diseases and asthma | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2013-10-29 | — | — | US | disclosed |
| US-20130217771-A1 | RESOLVINS: BIOEMPLATES FOR NOVEL THERAPEUTIC INTERVENTIONS | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. | 2013-08-22 | — | — | US | disclosed |
| US-20130150446-A1 | ANTI-INFLAMMATORY ACTIONS OF NEUROPROTECTIN D1/PROTECTIN D1 AND ITS NATURAL STEREOISOMERS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2013-06-13 | — | — | US | disclosed |
| US-20120264713-A1 | USE OF DOCOSATRIENES, RESOLVINS, AND THEIR STABLE ANALOGS IN THE TREATMENT OF AIRWAY DISEASES AND ASTHMA | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. | 2012-10-18 | — | — | US | disclosed |
| US-8273792-B2 | Anti-inflammatory actions of neuroprotectin D1/protectin D1 and it's natural stereoisomers | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2012-09-25 | — | — | US | disclosed |
| US-7872152-B2 | Di- and tri-hydroxy derivatives of eicosapentaenoic acid and docosahexaenoic acid coadministered with a cyclooxygenase-2 inhibitor; antiinflammatory agents | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2011-01-18 | — | — | US | disclosed |
| US-20090156673-A1 | ANTI-INFLAMMATORY ACTIONS OF NEUROPROTECTIN D1/PROTECTIN D1 AND IT'S NATURAL STEREOISOMERS | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. CORPORATE SPONSORED RESEARCH & LICENSING (US) | 2009-06-18 | — | — | US | disclosed |
| US-20080096961-A1 | Di- and tri-hydroxy derivatives of eicosapentaenoic acid and docosahexaenoic acid coadministered with a cyclooxygenase-2 inhibitor; antiinflammatory agents | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. | 2008-04-24 | — | — | US | disclosed |
| WO-2007041440-A2 | ANTI-INFLAMMATORY ACTIONS OF NEUROPROTECTIN D1/PROTECTIN D1 AND ITS NATURAL STEREOISOMERS | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2007-04-12 | — | — | WO | disclosed |
| EP-1725228-A2 | USE OF DOCOSATRIENES, RESOLVINS AND THEIR STABLE ANALOGS IN THE TREATMENT OF AIRWAY DISEASES AND ASTHMA | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2006-11-29 | — | — | EP | disclosed |
| US-20050261255-A1 | Di- and tri-hydroxy derivatives of eicosapentaenoic acid and docosahexaenoic acid coadministered with a cyclooxygenase-2 inhibitor; antiinflammatory agents | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2005-11-24 | — | — | US | disclosed |
| WO-2005089744-A2 | USE OF DOCOSATRIENES, RESOLVINS AND THEIR STABLE ANALOGS IN THE TREATMENT OF AIRWAY DISEASES AND ASTHMA | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2005-09-29 | — | — | WO | disclosed |
| EP-1537067-A2 | RESOLVINS: BIOTEMPLATES FOR THERAPEUTIC INTERVENTIONS | BRIGHAM AND WOMEN'S HOSPITAL (US) | 2005-06-08 | — | — | EP | disclosed |
| WO-2004014835-A9 | RESOLVINS: BIOTEMPLATES FOR THERAPEUTIC INTERVENTIONS | BRIGHAM & WOMENS HOSPITAL (US) | 2004-07-08 | — | — | WO | disclosed |
| US-20040116408-A1 | Resolvins: biotemplates for novel therapeutic interventions | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2004-06-17 | — | — | US | disclosed |
| WO-2004014835-A2 | RESOLVINS: BIOTEMPLATES FOR THERAPEUTIC INTERVENTIONS | BRIGHAM AND WOMEN'S HOSPITAL (US) | 2004-02-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130217771-A1 | RESOLVINS: BIOEMPLATES FOR NOVEL THERAPEUTIC INTERVENTIONS | PTGES3, ALOX5, PTGES2 | TSHR 4768/4885ALDH1A1 799/4885FAAH 84/4885 |
| US-20120264713-A1 | USE OF DOCOSATRIENES, RESOLVINS, AND THEIR STABLE ANALOGS IN THE TREATMENT OF AIRWAY DISEASES AND ASTHMA | PTGER3, PTGER2, ALOX5 | TSHR 4316/4885ALDH1A1 911/4885FAAH 114/4885 |
| US-20140179630-A1 | USE OF DOCASATRIENES, RESOLVINS, AND THEIR STABLE ANALOGS IN THE TREATMENT OF AIRWAY DISEASES AND ASTHMA | PTGER3, PTGER2, ALOX5 | TSHR 4293/4885ALDH1A1 922/4885FAAH 116/4885 |
| US-20080096961-A1 | Di- and tri-hydroxy derivatives of eicosapentaenoic acid and docosahexaenoic acid coadministered with a cyclooxygenase-2 inhibitor; antiinflammatory agents | ALOX5, PTGES2, PTGER3 | TSHR 4178/4885ALDH1A1 726/4885FAAH 75/4885 |
| US-20050261255-A1 | Di- and tri-hydroxy derivatives of eicosapentaenoic acid and docosahexaenoic acid coadministered with a cyclooxygenase-2 inhibitor; antiinflammatory agents | ALOX5, PTGES2, PTGES3 | TSHR 4343/4885ALDH1A1 768/4885FAAH 78/4885 |
| US-20130150446-A1 | ANTI-INFLAMMATORY ACTIONS OF NEUROPROTECTIN D1/PROTECTIN D1 AND ITS NATURAL STEREOISOMERS | PTGER1, PTGES, PTGS1 | TSHR 3888/4885ALDH1A1 1172/4885FAAH 81/4885 |
| US-20090156673-A1 | ANTI-INFLAMMATORY ACTIONS OF NEUROPROTECTIN D1/PROTECTIN D1 AND IT'S NATURAL STEREOISOMERS | ALOX15, ALOX12, ALOX15B | TSHR 3515/4885ALDH1A1 302/4885FAAH 170/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.